Psychiatry News

Adam Margolius, MD, neurology specialist at Cleveland Clinic, discusses the greatest challenges patients and physicians face in tardive dyskinesia care.

Adam Margolius, MD, neurology specialist at Cleveland Clinic, emphasizes the need for patients who are on medications that block dopamine to be screened often by a healthcare professional, whether that be a primary care specialist, neurologist or psychologist.

Adam Margolius, MD, neurology specialist at Cleveland Clinic, highlights the current treatment options for patients with tardive dyskinesia as well the future of TD care.

Adam Margolius, MD, neurology specialist at Cleveland Clinic, discusses recent medications that have been effective in calming excessive movements caused by tardive dyskinesia.

Patients with diabetes on one of several GLP-1 receptor agonists were less likely to be diagnosed with depression and anxiety compared with those not on those medications, researchers found.

Childhood bullying was linked to distrust as a teenager and mental health issues in late adolescence according to research published earlier this week.

The FDA has accepted and granted priority review to a new drug application for midomafetamine capsules used in combination with psychological intervention for PTSD, according to a press release from Lykos Therapeutics.

Dexmedetomidine administration early in the postpartum period was associated with significantly lower positive postpartum depression incidence compared with placebo, researchers reported in JAMA Network Open.

Older adults with a coronary artery calcium score of 0 had more favorable aging indices, including normal cognitive function, vascular function and better hearing, compared with those with CAC scores of 1,000 or greater, data show.

For most of us doctors, it’s the last thing we look at before bed and the first thing when we wake up: the screen of our smartphone or tablet.